Annual report pursuant to Section 13 and 15(d)

ACQUISITION (Details Narrative)

v3.22.4
ACQUISITION (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 01, 2021
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Weighted-average amortization period     3 years  
Revenue     $ 138,826,000 $ 139,599,000
Difference between actual revenue and pro forma revenue       157,390,000
medSR [Member]        
Business Acquisition [Line Items]        
Earnout, payment $ 13,000,000      
Fair value of contingent consideration 5,600,000     3,100,000
Consideration paid 1,500,000      
Revenue and backlog milestones, payments $ 500,000      
Additional shares held, terms 18 months      
Escrow, settlement   $ 250,000    
Working capital, adjustment   $ 250,000    
Escrow, deposit held     71,000  
Escrow, deposit     $ 1,000,000 1,000,000
Weighted-average amortization period     3 years  
Revenue     $ 29,700,000 15,900,000
Difference between actual revenue and pro forma revenue       $ 17,800,000
medSR Purchase Price [Member]        
Business Acquisition [Line Items]        
Cash     $ 12,300,000  
Asset and Stock Purchase Agreement [Member] | MedMatica [Member]        
Business Acquisition [Line Items]        
Consideration paid $ 10,000,000      
Working capital deficiency 3,800,000      
Maximum earn-out payments based upon achievements 8,000,000      
Additional maximum earn-out payments based upon achievements $ 5,000,000